Menu Close

Trending

An inside peek into pharma marketing at PM Society learning event – part i
SABCS: AZ’s oral SERD data may “relaunch enthusiasm” for class
SABCS: New ADC from AZ and Daiichi shows promise in breast cancer
PharmStars digital health accelerator names its second class of 2022
Autolus announces primary endpoint met in FELIX trial, prices public offering

Debates

 
Print

Debates/ R&D/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

How new data capabilities can supercharge clinical research

, , , 0 Comment

The UK’s health research data capabilities are rapidly evolving. For example, during the height of the pandemic, NIHR’s

X
How new data capabilities can supercharge clinical research
https://pharmaphorum.com/webinars/how-new-data-capabilities-can-supercharge-clinical-research/
 
Print

Debates/ R&D/ Webinars/ Webinars in home page/ Webinars On demand

The new global digital health paradigm in life sciences

, , , , , , 0 Comment

Digital transformation has long been a priority for all life science companies and it has been made even

X
The new global digital health paradigm in life sciences
https://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/
 
COVID-19-webinar-Image-16x9-Text

Debates/ R&D/ Webinars/ Webinars in home page/ Webinars On demand

COVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotech

, , , , 0 Comment

Overview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications

X
COVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotech
https://pharmaphorum.com/r-d/iqvia-covid-19-april-briefing-impact-for-pharma-and-biotech/
 
ERT Webinar

Debates/ Debates & Insights/ R&D/ Webinars/ Webinars On demand

Vaccines trials in the COVID-19 era and tech’s role in speeding studies

, , , , , , 0 Comment

Overview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus

X
Vaccines trials in the COVID-19 era and tech’s role in speeding studies
https://pharmaphorum.com/r-d/vaccines-trials-covid-19-coronavirus/
 
Coronavirus webinar

Debates/ Debates & Insights/ R&D/ Webinars/ Webinars On demand

The COVID-19 coronavirus and pharma and biotech continuity planning

, , , , , , 0 Comment

Overview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from

X
The COVID-19 coronavirus and pharma and biotech continuity planning
https://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/
 
QuDoS-webinar-Image-16x9-Text

Audio/ Debates/ Debates/ Debates/ Debates & Insight/ Debates & Insight/ Debates & Insights/ Digital/ Patients/ R&D/ Webinars/ Webinars On demand

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

, , , , 0 Comment

Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are

X
Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?
https://pharmaphorum.com/debates-insight-digital/digital-health-can-technology-used-engage-hard-reach-patients-assist-patient-monitoring/
 
QuintilesIMS Webinar 2017 Biologics_16x9_8June2017

Debates/ Debates/ Debates & Insight/ Debates & Insights/ Market Access/ Pharma Market Access/ R&D/ Webinars/ Webinars in home page/ Webinars On demand

20/06/2017

Disruption and maturity: the future directions for biologics

, , , 0 Comment

Is the UK’s NHS saving enough from the new wave of biosimilars?

X
Disruption and maturity: the future directions for biologics
https://pharmaphorum.com/debates-insight-market-access/disruption-maturity-future-directions-biologics/
1 2

Login

CONTINUE TO SITE >
X
Close in 10 seconds